Login

Galera Therapeutics, Inc. 8-K/A SEC Filings

Filed On Filing
24 Mar 2025 8-K/A: Financial Statements and Exhibits

The Company requested and was granted a waiver from the SEC that permits the Company to omit (i) the audited historical financial statements of the Acquired Company as of for the fiscal year ended December 31, 2023 and (ii) the unaudited...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support